CommercialCoverageMedium impact
Light and Laser Therapies for Dermatologic Conditions 8.01.21
Excellus BlueCross BlueShield·Dermatology·Skin (Dermatology)
Effective date
Oct 16, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has updated their policy for Light and Laser Therapies for Dermatologic Conditions, effective October 16, 2025. The policy establishes specific coverage criteria for various phototherapy treatments including UVB, PUVA, targeted phototherapy, and photodynamic therapy for conditions like psoriasis, eczema, and skin cancers.
Action Required
Before October 16, 2025: Review and update prior authorization processes for dermatologic light and laser therapies. Ensure documentation includes contraindication screening (xeroderma pigmentosum, light sensitivity disorders, lupus), evidence of failed conservative treatments, and specific condition severity. For home phototherapy, require dermatologist letter of medical necessity. Update billing staff training on the specific coverage criteria for UVB, PUVA, excimer laser treatments, and photodynamic therapy to prevent claim denials.